The Biotech Brief
The HEIIWe quickly breakdown the latest news in biotech. Fast Facts. Big Breakthroughs.
| Publishes | Daily | Episodes | 6 | Founded | 3 months ago |
|---|---|---|---|---|---|
| Categories | Life SciencesScience | ||||
Listen to this Podcast
Latest Episodes
Gilead’s twice-yearly injectable PrEP, Yeztugo was recently approved by the FDA, but the story doesn’t end there. In this episode of The Biotech Brief, we explore how Gilead is leveraging global partnerships, generics, and regulatory streamlining to ... more
Southwest Airlines is taking generic drugmakers to court and accusing more than 20 companies of price fixing that inflated costs for millions of Americans, including its own employees. In this episode of The Biotech Brief, we unpack the lawsuit, the ... more
Ocular Therapeutix is rebranding and repositioning. This episode of The Biotech Brief breaks down their plans for competing in the Wet AMD space, the company’s brand pivot to be more retina focused, and why this branding shift is more strategic than ... more
Novartis’ blockbuster Cosentyx has hit a wall. In this episode of The Biotech Brief, we unpack the Phase 3 GCAptAIN trial results, where Cosentyx failed to show benefit for patients with giant cell arteritis. We explore what GCA is, why this label ex... more
Regeneron has officially entered the multiple myeloma arena with FDA approval of Lynozyfic, a BCMA-targeted bispecific antibody for patients who’ve exhausted standard therapies. In this episode, we break down what Lynozyfic is, how it works, and how ... more
In the first episode of The Biotech Brief, we break down what Yeztugo is, why it matters, how it compares to daily pills, and what this means for the $45 billion HIV prevention market.
Key Facts
Host
Chart Rankings
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #233 |  United Kingdom/Science/Life Sciences |
Apple Podcasts | #170 |  Austria/Science/Life Sciences |
Top Life Sciences Podcasts
Audience Metrics
Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Frequently Asked Questions About The Biotech Brief
What is The Biotech Brief about and what kind of topics does it cover?
This podcast provides succinct breakdowns of significant developments in the biotechnology sector, focusing on both groundbreaking advancements and essential industry news. The discussions range from FDA approvals of new drugs to legal battles affecting drug pricing and accessibility, highlighting the intricate relationship between pharmaceutical companies, regulatory bodies, and public health outcomes. Listeners can expect targeted insights on novel treatments, ongoing clinical trials, and the challenges faced by biotech firms, making it a valuable resource for anyone interested in the fast-paced world of biomedicine.
A unique aspect of this content is its commitment to conveying complex topics in a concise format, appealing not only to i... more
Where can I find podcast stats for The Biotech Brief?
Rephonic provides a wide range of podcast stats for The Biotech Brief. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Biotech Brief and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
How many listeners does The Biotech Brief get?
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Biotech Brief, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
What are the audience demographics for The Biotech Brief?
Rephonic provides comprehensive predictive audience data for The Biotech Brief, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
How many subscribers and views does The Biotech Brief have?
To see how many followers or subscribers The Biotech Brief has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
How many episodes of The Biotech Brief are there?
The Biotech Brief launched 3 months ago and published 6 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
How do I contact The Biotech Brief?
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Where can I see ratings and reviews for The Biotech Brief?
Rephonic pulls ratings and reviews for The Biotech Brief from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
How do I access podcast episode transcripts for The Biotech Brief?
Rephonic provides full transcripts for episodes of The Biotech Brief. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.